Analysis of the potential biological value of pyruvate dehydrogenase E1 subunit β in human cancer

doi:10.4251/wjgo.v16.i1.144

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3255)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-14) series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

2147

Figures (1-14)

207

Tables (1-1)

204

Sum=2652

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

141

Download

353

Sum=494

Jan 15, 2024 (publication date) through Jan 1, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Jan 15, 2024; 16(1): 144-181
Published online Jan 15, 2024. doi: 10.4251/wjgo.v16.i1.144

Full Size Figure Download Figure

Figure 12 Drug sensitivity analysis. Correlation of IC₅₀ with pyruvate dehydrogenase E1 subunit β expression for different drugs. A: Chelerythrine; B: Nelarabine; C: Fludarabine; D: Fenretinide; E: Lapachone; F: Vorinostat; G: Dasatinib; H: Dolastatin 10. PDHB: Pyruvate dehydrogenase E1 subunit β.

Citation: Rong Y, Liu SH, Tang MZ, Wu ZH, Ma GR, Li XF, Cai H. Analysis of the potential biological value of pyruvate dehydrogenase E1 subunit β in human cancer. World J Gastrointest Oncol 2024; 16(1): 144-181
URL: https://www.wjgnet.com/1948-5204/full/v16/i1/144.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i1.144